Kratom Master Manufacturing Records and Batch Records: How One Lot Becomes Traceable

Suggested page: Learning Center → Lab Testing & Product Quality
Secondary phrases: kratom batch record, kratom master manufacturing record, kratom lot traceability, kratom production documentation
Suggested slug: /learn/kratom-batch-manufacturing-records/
Suggested SEO title: Kratom Batch Records: Manufacturing, Lot and Label Traceability | Kiody
Suggested meta description: Learn how master manufacturing records and batch production records connect kratom ingredients, equipment, yields, testing, labels, deviations and finished lots.

Kiody position: Kiody serves adults 21+ and does not sell concentrated 7-hydroxymitragynine (7-OH). Kiody pure-leaf capsules contain approximately 500 mg of leaf powder per capsule. This guide separates ordinary botanical leaf from extracts, enhanced products, concentrated 7-OH and synthesized or semi-synthesized derivatives. It makes no medical claims.

The short answer

A master manufacturing record describes how a particular product and batch size are supposed to be made. A batch production record documents what actually happened when one specific batch was made, packaged and labeled.

That distinction matters. A certificate of analysis can report selected results for a sample, but it does not normally show which component lots entered the blend, which equipment was used, whether scales were checked, what the theoretical and actual yields were, which label version was applied, who performed each step, what deviations occurred or who approved release. Those connections live in the production records and the surrounding quality system.

For an approximately 500 mg pure-leaf capsule, the master record might specify the approved leaf-powder component, capsule shell, target fill, acceptable in-process range, capsule count, packaging configuration and label. The completed batch record should then identify the actual leaf lot, shell lot, quantities weighed, equipment, dates, operators, in-process checks, yield, packaging lots, label reconciliation, laboratory references, deviations and final disposition.

A finished product can pass a laboratory test yet still have a serious documentation problem. Conversely, a neat batch record cannot rescue a product that fails identity, contamination, composition or legal requirements. Records and testing answer different questions and must work together.

An important regulatory boundary

FDA currently states that kratom is not lawfully marketed in the United States as a drug product, dietary supplement or food additive in conventional food. Nothing in this guide suggests that using dietary-supplement current good manufacturing practice concepts makes a kratom product FDA approved or lawful.

The detailed recordkeeping framework below comes primarily from 21 CFR Part 111, FDA’s current good manufacturing practice regulation for dietary supplements. It is useful educationally because it shows what a mature manufacturing record system is designed to control. Whether, how and to what extent a particular kratom business is subject to a specific federal, state or local requirement requires qualified legal review.

Quality documentation is not a legal-status certificate.

Why two different records are needed

Manufacturing needs both a controlled plan and an accurate history.

The controlled plan answers questions such as:

• What is the product?
• What batch size is authorized?
• Which components and quantities are required?
• Which specifications must be met?
• At what steps are checks necessary?
• What packaging and label are approved?
• What theoretical yield should result?

The batch history answers different questions:

• Which component lots were actually used?
• How much was actually weighed or dispensed?
• Which employees performed and verified the work?
• Which equipment and rooms were used?
• What were the real processing times and observations?
• What did in-process checks show?
• How much finished product was obtained?
• Which bottle, pouch, capsule shell and label lots were used?
• Did anything depart from the plan?
• What was investigated, rejected, reprocessed or approved?

If a business keeps only the plan, it cannot demonstrate that the plan was followed. If it keeps only informal production notes, it lacks a controlled standard against which the work can be evaluated.

What is a master manufacturing record?

Under 21 CFR §111.205, a dietary-supplement manufacturer must prepare and follow a written master manufacturing record for each unique formulation and each batch size. The purpose is batch-to-batch uniformity. The record must identify specifications at points where control is necessary and establish controls and procedures intended to ensure that each batch meets specifications and is packaged and labeled as specified.

In plain language, the master record is the approved manufacturing blueprint.

It should not be treated as a flexible suggestion. Changes to a component quantity, batch size, process step, packaging configuration or label should follow documented change control and approval rather than being improvised during production.

One formula may require several master records

A 25-kilogram leaf-powder batch and a 100-kilogram batch are not automatically governed by one interchangeable set of instructions. Mixing time, equipment capacity, sampling locations, yield expectations and process behavior may change with scale.

Likewise, the following are different products or configurations even if they use the same botanical source:

• bulk leaf powder in a 100-gram pouch;
• approximately 500 mg pure-leaf capsules in a 60-count bottle;
• approximately 500 mg pure-leaf capsules in a 120-count bottle;
• a measured botanical extract;
• leaf fortified with an extract;
• a liquid concentrate;
• a flavored multi-ingredient product; and
• a concentrated 7-OH product.

The more concentrated or complex the product, the more dangerous it is to assume that a leaf-powder record can simply be reused.

What belongs in a master manufacturing record?

Section 111.210 identifies detailed elements. A practical record should cover at least the following categories.

1. Product identity and strength or concentration

The record should state the product name and the intended strength, concentration, weight or measure of each dietary ingredient for each finished unit, or for the batch where appropriate.

For pure-leaf capsules, “500 mg capsule” can be misleading if it is not clear whether 500 mg refers to the nominal net leaf fill or the total weight including the shell. Kiody’s intended description is approximately 500 mg of pure leaf powder per capsule. The record should define how that target is calculated and checked.

For a powder pouch, the relevant quantity may be net product weight. For an extract, both the extract quantity and any declared concentration require clear definitions. For 7-OH-related decisions, the basis—dry weight, product weight, milligrams per gram, milligrams per serving or percentage of total alkaloids—must never be left ambiguous.

2. Complete component list

The master record should list every component intended for use. Depending on the product, that could include:

• approved Mitragyna speciosa leaf powder;
• capsule shells and their composition;
• excipients, if any;
• extract ingredients;
• flavor systems;
• carriers;
• processing aids where required to be controlled;
• bottles or pouches;
• closures, liners, seals and desiccants; and
• labels and inserts.

“Kratom capsules” is not a complete component list. The leaf and capsule shell must be traceable separately. A vegetarian capsule claim also requires support for the actual shell used.

3. Exact component quantities

The record should state the weight or measure of each component. It should account for intentional overage only where appropriate and documented. An overage is not a license to add extra active material casually.

For pure-leaf capsules, the calculation connects:

1. intended capsule count;
2. target net leaf fill per capsule;
3. expected process loss;
4. required leaf-powder quantity; and
5. expected finished yield.

If 10,000 capsules target approximately 500 mg of leaf each, the nominal finished leaf content is about 5,000 grams before documented process considerations. That arithmetic is only a planning example; an actual master record needs approved quantities, ranges and scale-specific process knowledge.

4. Theoretical yield and acceptable limits

Theoretical yield is what the process should produce based on authorized inputs. Actual yield is what it did produce. The master record should identify expected yield at appropriate stages and the acceptable percentage of theoretical yield.

Yield differences can reveal:

• weighing or transcription errors;
• material remaining in equipment;
• excessive dust loss;
• incorrect capsule fill;
• rejected units;
• packaging-count errors;
• undocumented rework;
• component mix-ups; or
• possible diversion or unexplained loss.

A yield outside the approved range should not be “fixed” by editing the target after production. It should trigger documented review.

5. Packaging and label description

The master record should describe the packaging and include a specimen or copy of each label or a reliable reference to the approved version.

This connects the formulation to the package the customer receives. It helps prevent a 60-count label from being placed on a 120-count bottle, a powder label from being used on capsules or an outdated warning panel from being applied to a current lot.

Labels are components. Their issuance, use, return and destruction need control just like ingredients.

6. Written manufacturing instructions

Instructions should identify the points, steps or stages where controls are needed. They may cover:

• line clearance before work begins;
• room and equipment readiness;
• component status verification;
• weighing and independent verification;
• screening or sieving parameters;
• blending order and time;
• capsule-machine setup;
• in-process fill-weight frequency;
• metal detection or other controls where applicable;
• bulk hold conditions;
• packaging counts;
• seal checks;
• coding of lot and date information;
• label reconciliation;
• sampling; and
• quality-unit review and release.

Instructions should be specific enough that trained employees can perform the same controlled process without relying on unwritten tribal knowledge.

What is a batch production record?

Under 21 CFR §111.255, a batch production record is prepared every time a batch of a dietary supplement is manufactured. It must accurately follow the appropriate master manufacturing record and document the production and control of the batch.

In plain language, the batch record is the contemporaneous evidence of what actually occurred.

“Contemporaneous” matters. Records entered while work is performed are generally more reliable than a form reconstructed from memory at the end of the week. Backfilling missing times, quantities or signatures undermines the record’s purpose.

What must a completed batch record show?

Section 111.260 provides the core requirements. A useful record connects material, people, equipment, processing, examination, packaging and disposition.

Batch and lot numbers

The record should identify the finished batch number and the lot or control number assigned to each packaged and labeled lot. If one finished bulk batch is packaged into different sizes, each packaged lot needs a traceable relationship to that bulk batch.

The record should also identify the unique identifier assigned to every component, packaging item and label used.

This creates the genealogy:

supplier leaf lot → internal component ID → finished bulk batch → packaged lot → customer shipment

Without that chain, a complaint or recall can become unnecessarily broad because the business cannot determine which finished products share the same source material.

Equipment and processing lines

The batch record should identify the equipment and processing lines used. Equipment identification connects the batch to cleaning, maintenance and calibration records.

“Blender 1” is useful only if Blender 1 has a unique identity and associated history. The same applies to balances, capsule machines, sifters, filling lines, labelers, metal detectors and environmental instruments.

Dates and times

The record should state the date and time of maintenance, cleaning and sanitizing—or cross-reference records where those events are documented—as well as the dates and times of manufacturing steps.

Time can matter when assessing:

• whether equipment was clean and released;
• how long material remained exposed;
• whether a bulk hold exceeded its limit;
• whether steps occurred in the intended order;
• whether samples represent the correct stage; and
• whether production overlapped with another material on shared equipment.

Actual component quantities

The batch record should document the identity and weight or measure of each component used. It should capture actual values rather than copying planned quantities automatically.

If the master record calls for 25.000 kilograms and the actual verified weight is 25.036 kilograms, the real entry matters. Whether it is acceptable depends on the approved range and the measurement system.

In-process and finished results

The record should contain or reference results of monitoring, testing and examinations. Examples may include:

• component release status;
• botanical identity confirmation;
• blend observations;
• capsule net-fill checks;
• count checks;
• seal-integrity checks;
• net-content checks;
• label and code verification;
• microbial results;
• heavy-metal results;
• pesticide or mycotoxin results where specified;
• alkaloid results; and
• finished-product specification disposition.

The batch record does not need to reproduce every laboratory page if it contains a controlled reference that reliably links the correct report and sample to the batch.

Actual yield and theoretical-yield comparison

The record should show actual yield and percentage of theoretical yield at appropriate phases. A simple calculation is:

percent yield = actual acceptable output ÷ theoretical output × 100

The quantities must use compatible units and a defined stage. Comparing kilograms of bulk blend to the number of finished bottles without a conversion model creates a meaningless percentage.

Packaging and label reconciliation

Reconciliation compares labels or packaging issued with those used, returned and destroyed. It helps identify unexplained discrepancies.

For example:

• 1,050 labels issued;
• 1,000 applied to saleable units;
• 12 damaged and destroyed;
• 38 unused and returned;
• total accounted for: 1,050.

An unexplained missing label is not merely a paper problem. It could be applied to the wrong product or used outside the controlled operation.

Employee initials or signatures

The record should identify the people who performed and verified significant steps. A signature should mean that the person actually performed or directly checked the stated activity—not that someone signed a stack of pages later.

Electronic systems may use secure, attributable electronic records. Shared logins defeat attribution.

Deviations, investigations and material review

The batch record should include documentation of any material review and disposition decision and explain reprocessing or reworking when performed.

A deviation is not automatically proof that a product is unsafe. It is evidence that the approved plan was not followed or an unexpected event occurred. The quality of the response depends on whether the event was promptly documented, scientifically evaluated and appropriately resolved.

Examples include:

• blend time shorter than instructed;
• balance check outside tolerance;
• capsule fills trending low;
• incorrect label roll brought to the line;
• bulk material held beyond the approved time;
• damaged seal;
• yield outside range;
• sample container mislabeled;
• laboratory result outside specification; or
• equipment alarm during processing.

The wrong response is to erase the event. The appropriate response is to preserve the facts, assess affected material, investigate the cause, determine disposition and take corrective or preventive action when warranted.

The quality unit’s role

Part 111 assigns quality-control personnel specific responsibilities for master records, batch records and manufacturing operations. Quality review should be more than confirming that every blank contains ink.

A meaningful review asks:

• Was the approved master-record version used?
• Were all components released before use?
• Do actual weights fall within authorized limits?
• Were required verifications performed?
• Do in-process results meet criteria?
• Are laboratory reports linked to the correct batch and sample?
• Are yields plausible and reconciled?
• Are labels and packaging accounted for?
• Were deviations investigated before release?
• Does the record support the final disposition?

The person approving release should have the authority to reject or hold a batch when the evidence is incomplete.

Five worked examples

Example 1: Pure-leaf powder pouch

A master record authorizes a 50-kilogram batch of botanical leaf powder packaged into 100-gram pouches. The record identifies the approved leaf component, screening step, blend or homogenization instruction, sampling plan, pouch and zipper specification, label version, net-weight check and expected yield.

The batch record identifies two supplier leaf lots combined into the finished batch. It documents actual weights, equipment, processing times, sample ID, test-report references, 487 acceptable pouches, process remnants, rejected pouches and label reconciliation.

The key lesson: the consumer-facing lot number should connect to both supplier lots, not merely to the day the pouches were filled.

Example 2: Approximately 500 mg pure-leaf capsules

The master record states a target of approximately 500 mg net leaf powder per capsule, the permitted in-process range, check frequency and bottle count.

During production, the first ten capsules average below the approved lower limit. The operator adjusts the machine, segregates the affected units and repeats the check. The batch record preserves both the failing initial result and the acceptable repeat after adjustment.

The key lesson: a passing later check should not erase the earlier result. The record should show what happened to capsules produced before correction.

Example 3: Correct product, wrong label version

A batch meets chemical and microbiological specifications, but line clearance finds an outdated label roll staged beside the packaging line. No bottles have been labeled.

The outdated labels are removed and reconciled, the correct version is issued and the event is documented. The batch may remain suitable because the issue was caught before application, but the near miss can still justify a process improvement.

The key lesson: a COA cannot reveal a label-control failure.

Example 4: Extract with unexplained yield gain

An extract batch produces substantially more finished liquid than the theoretical yield permits. Adding unrecorded water, using the wrong concentration assumption, scale error and transcription error are possible explanations.

The batch should remain on hold until the discrepancy is investigated. Simply changing the theoretical yield would destroy the comparison and conceal the problem.

The key lesson: an unexpectedly high yield can be as important as a low yield.

Example 5: Product near a 7-OH threshold

A finished product is tested near a legal or internal 7-OH boundary. The batch record must connect the result to the correct sample, batch, serving definition, moisture basis, unit conversion and laboratory method.

The manufacturing record does not itself determine legality. A separate current-law review is necessary, and uncertainty near a boundary requires a documented decision rule.

The key lesson: excellent records improve the reliability of the decision, but they do not create a legal safe harbor.

A proposed 30-field Kiody batch-review record

For internal review, Kiody could require the following fields before treating a lot record as complete:

1. Finished product name.
2. Product form.
3. Finished batch number.
4. Packaged lot number.
5. Master-record document number.
6. Master-record revision.
7. Authorized batch size.
8. Manufacturing site.
9. Manufacturing-room or line ID.
10. Major equipment IDs.
11. Leaf supplier and supplier lot.
12. Internal leaf-component ID.
13. Capsule-shell or packaging supplier lots.
14. Other component names and lots.
15. Planned component quantities.
16. Actual component quantities.
17. Weighing employee and date/time.
18. Independent verification where required.
19. Equipment readiness or cleaning reference.
20. Processing-step dates and times.
21. In-process checks and results.
22. Sample and chain-of-custody IDs.
23. Laboratory report numbers.
24. Theoretical yield.
25. Actual acceptable yield.
26. Yield percentage and approved range.
27. Packaging and label reconciliation.
28. Deviations, investigations and dispositions.
29. Quality review and release decision.
30. Distribution or inventory linkage.

This is a proposed transparency and review framework, not a claim that these fields alone satisfy every law or every manufacturing context.

What a retailer or business buyer can reasonably request

Full manufacturing records can contain confidential formulas, supplier information and operational details. Transparency does not require publishing every page.

A retailer can reasonably seek evidence that the system exists, such as:

• a lot-specific COA;
• a lot-number match among product, COA and invoice;
• confirmation that a controlled master record exists;
• confirmation that a completed batch record was quality reviewed;
• product-form and serving definitions;
• manufacturing-site identity;
• appropriate audit or qualification information;
• a summary of deviation status;
• recall contact information; and
• a statement of whether the lot was released, rejected or conditionally held.

“Proprietary” can justify redaction. It should not be used to avoid proving that the sold lot exists in a controlled traceability system.

What consumers can check without seeing the batch record

Consumers normally do not receive a full production file, but they can still look for outward signs of traceability:

1. A legible lot or batch number on the product.
2. A COA that names or links to the same lot.
3. A product description matching the tested form.
4. A responsible business name and contact route.
5. A clear net quantity and ingredient statement.
6. Serving information that does not conflict with the laboratory report.
7. A current label rather than a generic image detached from the actual package.
8. A recall or complaint process that asks for the lot number.

These signs do not guarantee compliance, but their absence makes meaningful traceability difficult.

Ten batch-record warning signs

1. The finished product has no lot number.
2. The COA lot does not match the package.
3. One identical COA is used for every product and date.
4. The record does not identify component lots.
5. Planned quantities are copied as actual quantities without measurements.
6. Dates or signatures appear to have been added long after production.
7. Yield is missing or implausible.
8. Failed or unusual results disappear after a retest.
9. Packaging and labels are not reconciled.
10. Release occurred before required results or deviation reviews were complete.

Batch records and the current federal 7-OH landscape

As of this draft date, DEA’s July 6, 2026 notice proposing temporary Schedule I placement of 7-OH above a specified threshold remains a proposal, with the comment period extended through September 10, 2026. It proposes a 0.050% dry-weight threshold and an alternative article trigger described in the notice. It must not be presented as an already effective nationwide 7-OH threshold.

A separate DEA order temporarily placing mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I became effective August 26, 2026. DOJ announced enforcement discretion for only incidental trace mitragynine pseudoindoxyl in a product otherwise consistent with botanical kratom. That statement provides no numerical trace threshold or legal safe harbor and does not extend to MGM-15 or MGM-16.

Batch documentation becomes especially important when product form, processing history and intentionally added or concentrated material affect legal review. However, a batch record cannot override federal, state or local law.

Frequently asked questions

1. Is a master manufacturing record the same as a batch record?

No. The master record is the approved plan for a product and batch size. The batch production record documents the actual execution and outcome of one batch.

2. Is a COA a batch record?

No. A COA reports selected laboratory results for a sample. A batch record connects components, equipment, processing, yields, packaging, labels, deviations and release.

3. Does every bottle need a unique batch number?

Units from the same packaged lot can share a lot number. The number must reliably connect them to the applicable finished batch and records.

4. Can several supplier lots be used in one finished batch?

They can be combined only under an appropriate controlled process. Every supplier lot and quantity should remain traceable to the finished batch.

5. Why document the capsule shell separately?

The shell is a component with its own composition, supplier, lot and possible quality considerations. “Pure-leaf capsule” describes the fill; it does not eliminate the shell.

6. Does approximately 500 mg mean every capsule weighs exactly 500 mg?

No manufacturing process produces perfectly identical units. The master record should define the target, permitted range, sampling frequency and response to results outside the range. The claim should clearly refer to net leaf fill when that is intended.

7. What is label reconciliation?

It is accounting for labels issued, used, damaged, destroyed and returned. Unexplained discrepancies can indicate a mix-up or uncontrolled label use.

8. Can a manufacturer correct a batch record?

Legitimate corrections should preserve the original information, identify the correction, state who made it and when, and explain it where necessary. Entries should not be erased or obscured.

9. Is an electronic batch record acceptable?

Electronic systems can support controlled records when access, attribution, versioning, security, review and retention are appropriate. A spreadsheet anyone can overwrite without history is not equivalent to a controlled system.

10. Does a deviation mean the batch must be destroyed?

Not automatically. The event requires documented evaluation. Some deviations can be scientifically resolved; others require rejection, reprocessing or broader investigation.

11. Why compare actual and theoretical yield?

The comparison helps identify unexplained loss, gain, errors, mix-ups, incorrect fills and unrecorded material movement.

12. Should a batch be released before lab results arrive?

If required specifications depend on those results, release before review would defeat the control. The record should show the product remained appropriately held until the quality decision.

13. Do records prove a product is safe?

No single record proves absolute safety. Good records make inputs, actions, results and decisions traceable. They work with testing, sanitation, supplier controls, complaints and other quality systems.

14. Do Part 111-style records make kratom legal?

No. FDA’s current position on kratom must be addressed separately, along with controlled-substance rules and state and local restrictions.

15. Should consumers receive the complete batch record?

Usually not. Full records may contain protected business information. Consumers should still receive a lot number and meaningful access to lot-specific quality information.

16. Does Kiody sell concentrated 7-OH?

No. Kiody is 21+ and does not sell concentrated 7-OH.

Primary sources

1. 21 CFR Part 111 — Dietary Supplement CGMP
2. 21 CFR §111.205 — requirement for a master manufacturing record
3. 21 CFR §111.210 — required master-record content
4. 21 CFR §111.255 — batch-production-record requirement
5. 21 CFR §111.260 — required batch-record content
6. 21 CFR §111.105 — quality-control operations for manufacturing records
7. FDA — Dietary Supplement CGMP Small Entity Compliance Guide
8. FDA — FDA and Kratom
9. Federal Register — proposed 7-OH specified-threshold scheduling notice
10. Federal Register — 7-OH comment period extended through September 10, 2026
11. Federal Register — effective MP, MGM-15 and MGM-16 temporary order
12. DOJ — August 25, 2026 enforcement-discretion announcement